Sources of information for new drugs among physicians in Thailand

Pharmacy World and Science

Volumn 29, Issue 6, 2007, Pages 619-627

  Layton, Maneerat R ^a   Sritanyarat, Wanapa ^a   Chadbunchachai, Supatra ^a   Wertheimer, Albert I ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Drug information; Pharmacists; Physicians; Prescribing; Thailand

Indexed keywords

NEW DRUG;

ARTICLE; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG SAFETY; FEMALE; HUMAN; MALE; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PHYSICIAN; PRESCRIPTION; QUALITATIVE RESEARCH; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SEMI STRUCTURED INTERVIEW; TEACHING HOSPITAL; THAILAND;

DRUG INFORMATION SERVICES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; PERIODICALS AS TOPIC; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; THAILAND;

EID: 35348842133     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9112-4     Document Type: Article

References (30)

1. Williams JR, Hensel PJ. Changes in physicians' sources of pharmaceutical information: a review and analysis. J Health Care Mark 1991;11(3):46-60.
2. Haug JD. Physicians' references for information sources: a meta-analytic study. Bull. Med Libr Assoc 1997;85:223-32.
3. Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA 2001;285(15):2009-12.
4. Angel M. The pharmaceutical industry - to whom is it accountable? NEJM 2000;342(25):1902-4.
5. Jones MI, Greenfield SM, Bradley CP. Prescribing new drugs: Qualitative study of influences on consultants and general practitioners. Br Med J 2001;323(7309):378-81.
6. Loke TW, Koh FC, Ward JE. Pharmaceutical advertisement claims in Australian medical publications. Med J Aust 2002;177(6):291-93.
7. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992;116(11):912-19.
8. Wade VA, Mansfield PR, McDonald PJ. Drug companies evidence to justify advertising. Lancet 1989;2:1261-64.
9. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA 1995;273(16):1296-98.
10. Goodman B. Do drug company promotions influence physician behavior?. West J Med 2001;174:232-33.
11. Kongpatanakul S, Somhom P, Panichpathompong U, Supatchaipisit P, Limcharoensuk S. Physicians' attitudes toward pharmaceutical sales representatives. Thai J Pharmacol 1997;19(1):23-32.
12. Hornby AS. New oxford advanced learners' dictionary of current English, Oxford: Oxford University Press; 2000.
13. National prescribing service. Case study 18: Considering a new drug. http://www.nps.org.au (18 Jun. 2003).
14. ACNielsen HCI. Important sources of medical information. http://www.perq-hci.com/News/research/important_sources.pdf (10 Feb. 2005).
15. Peay MY, Peay ER. Patterns of preference for information sources in the adoption of new drugs by specialists. Soc Sci Med 1990;31(4):467-76.
16. Manning PR, Denson TA. How internists learned about cimetidine. Ann Intern Med 1980;92:690-92.
17. Haynes F, Davis D, McKibbon A, et al. A critical appraisal of the efficacy of continuing medical education. JAMA 1982;251(1):61-64.
18. Wertheimer AI, Levy R, O'Connor T. Too many drugs? The clinical and economic value of incremental innovations. Res Human Cap Dev 2001;14:77-118.
19. Psaty BM, Furberg CD. COX-2 Inhibitors - Lessons in drug safety. NEJM 2005. http://www.content.nejm.org/cgi/content/abstract/NEJMe058042v1 (17 Feb. 2005).
20. Spath HM, Charavel M, Morelle M, Carrere MO. A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey. Pharm World Sci 2003;25(6):269-75.
21. Lexchin J. What information do physicians receive from pharmaceutical representatives?. Can Fam Physician 1997;41:1293-95.
22. Monaghan M, Galt K,Turner P, et al. Student understanding of relationship between the health professions and the pharmaceutical industry. Teach Learn Med 2003;15(1):14-20.
23. Shearer SW, Gagnon JP, Eckel FM. Community, hospital and clinical pharmacists and drug information centers as physician drug information sources. Am J Hosp Pharm 1978;35(8):909-14.
24. Millonig MK, Jackson TL, Ellis WM. Improving medication use through pharmacists' access to patient-specific health care information. J Am Pharm Assoc (Wash) 2002;42(4):638-45.
25. McGettigan P, Golden J, Fryer J, et al. Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 2001;51(2):184-89.
26. Avorn J. Pharmacy's wake-up call. Am J Health Syst Pharm 2004;61(15):2364.
27. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 1990;263(4):549-56.
28. McAvoy B, Kaner E. General practice postal surveys: a questionnaire too far?. Br Med J 1996;313:732-33.
29. Prakongsai P. Dual practice among public medical doctors in Thailand. http://www.essentialdrugs.org/edrug/achive/200311/msg00018.php.(2 Feb. 2004).
30. Vichyanond P, Hatchaleelaha S, Jintavorn V, Kerdsomnuig S. How pediatricians manage asthma in Thailand. Pediatr Pulmonol. 2001;32(2):109-14.